Company profile
DaltonTx
AI-enabled platforms for drug discovery in pharma, biotech, and CROs.
- Category
- Healthcare AI
- Headquarters
- London
- Sells to
- Enterprise
- Business model
- Other
- Deployment
- Cloud / SaaS
- Pricing
- Not published
- Builds own models
- Yes
- Modalities
- Tabular
What DaltonTx does
DaltonTx redefines drug discovery with adaptive, AI-enabled platforms that provide an intelligence engine for tomorrow's medicines. These platforms are purpose-built for small molecules and biologics, integrating seamlessly into scientific workflows and learning from every experiment to accelerate the path from idea to medicine. Unlike traditional project-based models, DaltonTx offers lasting capability through collaborative systems combining machine learning, software engineering, and deep drug discovery expertise. The technology learns from scientists, models, and experiments, guiding better decisions and evolving with scientific advancements to deliver breakthrough therapies faster. Founded by scientists for scientists, DaltonTx focuses on transforming the economics, timelines, and outcomes of discovery.
Key capabilities
- Adaptive, AI-enabled platforms
- Integrates seamlessly into scientific workflows
- Learns from every experiment
- Collaborative systems combining machine learning, software engineering, and deep drug discovery expertise
- Technology that learns from every scientist, model, and experiment
- Secure cloud-native infrastructure
- Fuses human expertise with machine intelligence
- Covers the full discovery lifecycle (data ingestion, model training, molecule generation, experiment prioritisation)
- Purpose-built AI cloud platform for biologics and small molecules
Use cases
- Powering drug discovery
- Accelerating the path from idea to medicine
- Improving drug discovery decisions
- Transforming the economics, timelines, and outcomes of discovery
- Creating AI-enabled drug discovery capability
AI approach
DaltonTx provides adaptive, AI-enabled platforms for drug discovery, integrating machine learning, software engineering, and drug discovery expertise. Their technology learns from every experiment, scientist, and model, guiding better decisions and evolving with the science. It covers the full discovery lifecycle including data ingestion, model training, molecule generation, and experiment prioritization.
Tech named: machine learning, AI-enabled platforms
Industries served
- Pharma
- Biotech
- CROs
What it says sets it apart
- Adaptive intelligent system that evolves with science
- Integrates seamlessly into workflows
- Puts lasting capability in hands of users
- Technology learns from every scientist, model, and experiment, getting smarter over time
- Built by scientists, for scientists
- Combines software engineering, machine learning, and deep drug discovery expertise
- Proven track record across small molecules and biologics
- Breakthrough performance on hardest discovery challenges
- Scientific team rooted in academic excellence (University of Oxford) and decades of real-world industry experience
Funding rounds we track
Seedcamp, Redalpine, IQ Capital Partners, Oxford University Innovation
From the AI funding tracker — rounds as reported by the linked publications.
This profile was compiled from DaltonTx's own public pages in July 2026 and reflects what the company states about itself — not an endorsement or an independent audit of those claims. Facts are extracted with AI and filtered by an automated check that drops any named product, customer or certification missing from the source pages. Full method. Something out of date? Tell us.